Laura O'Dell

Laura O'Dell, CFA, is an analyst at Diamond Hill Capital Management, Inc., based in Columbus, Ohio. In this role, she specializes in the health care sector, with a particular focus on areas such as genomics and immunology. Her responsibilities include evaluating trends, companies, and innovations across the health care industry, informing investment decisions for the firm's portfolios.

Prior to joining Diamond Hill in 2015, O'Dell served as a Principal at Aventis Pharmaceuticals, building a strong foundation in the biotechnology and pharmaceutical sectors. She is frequently featured in industry discussions and podcasts for her expertise on the impact of scientific advancements and regulatory changes within health care, including topics such as pandemics and vaccine development.

O'Dell holds a Master’s degree in Immunology and a Bachelor of Science in Biology and Education, underscoring her deep technical expertise. She is a CFA charterholder, reflecting her commitment to rigorous investment analysis and ethical standards. O'Dell is known for her passion for continuous learning and is recognized for her organization and ability to distill complex scientific topics for investors.